Mörsdorf K, Wolf G
Arzneimittelforschung. 1977;27(3):531-3.
In a comparative study new antiinflammatory agents, like sodium-(3-[(2,6-dichlorephenyl)-amino5-phenyl)-acetate (diclofenac); d,l-2-(3-phen0xy-phenyl) propionic acid (fenoprofen); 2-(3-benzoxyl-phenly-propionic acid (ketoprofen); cis-5-fluoro-2-methyl-1-(p-methylsulfinyl) benzylideryl-3-indenyl-acetic acid (MK 231, sulindac); 2-(6-methoxy-2-naphthyl)-propionic acid (naproxen/, showed nearly the same antiiflammatory effectiveness as 5-methoxy-2-methyl-1-(4-chlorobenzoyl)-indolyl-(3)-acetic acid (indometacin). In homogenates of inflamed rat paws an antiproteolytic activity of the new antiinflammatory agents was lacking.
在一项比较研究中,新型抗炎药,如(3-[(2,6-二氯苯基)-氨基-5-苯基]乙酸钠(双氯芬酸);d,l-2-(3-苯氧基苯基)丙酸(非诺洛芬);2-(3-苯并氧基苯基)丙酸(酮洛芬);顺式-5-氟-2-甲基-1-(对甲基亚磺酰基)苄叉基-3-茚基乙酸(MK 231,舒林酸);2-(6-甲氧基-2-萘基)丙酸(萘普生),显示出与5-甲氧基-2-甲基-1-(4-氯苯甲酰基)-吲哚-3-乙酸(吲哚美辛)几乎相同的抗炎效果。在炎症大鼠爪的匀浆中,新型抗炎药缺乏抗蛋白水解活性。